Role of Endocrine-Disrupting Engineered Nanomaterials in the Pathogenesis of Type 2 Diabetes Mellitus
Version 2 2024-09-20, 03:15Version 2 2024-09-20, 03:15
Version 1 2024-09-20, 03:11Version 1 2024-09-20, 03:11
journal contribution
posted on 2024-09-20, 03:15 authored by A Priyam, PP Singh, S GehloutRole of Endocrine-Disrupting Engineered Nanomaterials in the Pathogenesis of Type 2 Diabetes Mellitus
History
Journal
Frontiers in EndocrinologyVolume
9Article number
ARTN 704Location
SwitzerlandISSN
1664-2392eISSN
1664-2392Language
EnglishPublication classification
C1 Refereed article in a scholarly journalPublisher
FRONTIERS MEDIA SAPublication URL
Usage metrics
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineEndocrinology & Metabolismengineered nanomaterial (ENM)type 2 diabetes mellitus (T2DM)endocrine disruptorinsulin resistancereduced insulin sensitivityoxidative stressin vitro and in vivo studiesepidemiological evidencesTITANIUM-DIOXIDE NANOPARTICLESCHROMIUM NANOCOMPOSITE SUPPLEMENTATIONBETA-CELL DYSFUNCTIONGOLD NANOPARTICLESOXIDE NANOPARTICLESOXIDATIVE STRESSOCCUPATIONAL-EXPOSURESILVER NANOPARTICLESORAL-EXPOSUREIN-VIVO
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC